Printer Friendly

ELAN/AMERICAN CYANAMID WITHDRAW MOTION FOR INJUNCTIVE RELIEF AGAINST CIBA-GEIGY

                ELAN/AMERICAN CYANAMID WITHDRAW MOTION
                FOR INJUNCTIVE RELIEF AGAINST CIBA-GEIGY
    NEWARK, N.J., Dec. 19 /PRNewswire/ -- Elan Corporation, plc (AMEX: ELN) and American Cyanamid Company (NYSE: ACY) said today they withdrew their motion for a preliminary injunction to halt the marketing of a nicotine transdermal patch by Ciba-Geigy Corporation.  A hearing on this matter has been scheduled for tomorrow, Dec. 20, in U.S. District Court in Newark.
    Elan and American Cyanamid said the motion was withdrawn because the urgency for relief on the basis of irreparable damages no longer had an adequate legal foundation due to a decision last Friday by a U.S. District court judge in Northern California to lift a temporary restraining order against the marketing of a nicotine patch by Marion Merrell Dow, Inc.
    Elan and American Cyanamid are continuing their patent infringement actions against Ciba-Geigy, Marion Merrell Dow, Inc. and Alza Corporation and said they will pursue aggressive protection of their rights.
    -0-       12/19/91
    /CONTACT: Brian Crotty of Elan, 800-252-3526, or Thomas Redington of Redington, Inc., 212-926-1733 or 203-222-7399, for Elan/
    (ELN ACY) CO:  Elan Corporation, plc; American Cyanamid Company;
     Ciba-Geigy Corporation ST:  New Jersey IN:  MTC SU: FC-JT -- NY090 -- 4156 12/19/91 18:05 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 19, 1991
Words:205
Previous Article:SPREAD THE WORD, NOT THE DISEASES (Product Announcement)
Next Article:WASHINGTON U. RESEARCHERS, CYTOTHERAPEUTICS REPORT DIABETES RESEARCH ADVANCE IN SCIENCE; ISLET CELL IMPLANTS UNDER SKIN CONTROL GLUCOSE LEVEL
Topics:


Related Articles
ELAN: COURT ADVANCES HEARING DATE FOR NICOTINE PATCH DISPUTE
AMERICA ENCOURAGED TO STOP SMOKING IN 1992
ALZA, CYANAMID, ELAN AND MARION MERRELL CONCLUDE AGREEMENTS AND REACH AN OUT-OF-COURT SETTLEMENT
ELAN ADDS $200 MILLION OF NICOTINE PATCH PRODUCTION CAPACITY WITH SECOND UNIT; U.S. MARKET SHARE NOW AT 30 PERCENT
SUPPLY OF HABITROL(TM) NICOTINE PATCH RETURNS TO NORMAL
CIBA CONSUMER PHARMACEUTICALS REACHES AGREEMENT WITH FISONS PLC
CIBA-GEIGY CORP AND CIBA-GEIGY CANADA LTD. COMPLETE PURCHASE OF FISONS' NORTH AMERICAN CONSUMER HEALTHCARE BUSINESS
NICOTINE PATCH AGREEMENT SIGNED
EDWARD MADIGAN NAMED ADVISOR TO CIBA'S GOVERNANCE COMMITTEE
ELAN ANNOUNCES NICOTINE PATCH PATENT SETTLEMENT WITH CIBA GEIGY

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters